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Background: The cross-cultural validity of the Health Assessment Questionnaire Disability 
Index (HAQ-DI) in psoriatic arthritis (PSA) has not been well studied.  
Objectives: To assess the validity of the HAQ-DI in PSA and determine its invariance to 
different patient characteristics including culture.  
Methods: We analysed HAQ-DI data from patients with PsA in 5 cultural regions (the UK, N. 
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construct validity, person separation index (PSI) reliability, unidimensionality, targeting and 
the invariance of the scale across patient characteristics (culture, age, gender, disease 
duration, disease type and extent of skin involvement). 
Results: The dataset comprised 503 patients (286 women) from 15 countries. Their mean 
(SD) age was 50.8 (13.1), psoriasis duration, 18.4 (13.7) years and PSA duration, 9.8 (9.9) 
years.  
Table 1 presents the summary statistics for the overall model fit (F2 interaction) and 
reliability (PSI). The fit statistics suggest adequate fit to the model and acceptable reliability 
in all individual cultural groups and except S. America and Asia where sample sizes were 
limited (not shown).  
The HAQ-DI was unidimensional and invariant to all personal characteristics in the N. 
America dataset. In the pooled dataset, the HAQ-DI displayed differential item functioning 
(DIF) by type of arthritis, where those with oligoarthritis were more likely to have lower 
scores on the dressing & grooming item than those with polyarthritis. Floor effects were 
evident, especially in oligoarthritis. Using the DIF-free population (N. America), the HAQ-DI 
was shown to be well-targeted and discriminated well between the two types of arthritis 
(graph not shown). 
Conclusions: In Europe and N America, HAQ-DI is a cross-culturally valid and reliable 
measure of disability in PsA and Rasch-transformed values can be used with confidence 
alongside other outcome measures in parametric analyses. 
Table 1: Overall model fit statistics for HAQ-DI 
Region F2 interaction statistic (P-value) PSI Reliability 
UK 8.5746 (0.379) 0.885 
North America 5.299 (0.725) 0.860 
Europe (excluding UK) 25.356 (0.064) 0.855 
Pooled data 76.310 (0.037) 0.857 
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